Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician

References

• GOLD. The global strategy for diagnosis, management and prevention of COPD, 2022 report; 2022. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed November 1, 2022.
   Google Scholar
• von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507–509. doi:10.1002/jcsm.12167
   PubMed Web of Science ®Google Scholar
• Kwan HY, Maddocks M, Nolan CM, et al. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study. J Cachexia Sarcopenia Muscle. 2019;10(6):1330–1338. doi:10.1002/jcsm.12463
   PubMed Web of Science ®Google Scholar
• McDonald MN, Wouters EFM, Rutten E, et al. It’s more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res. 2019;20(1):100. doi:10.1186/s12931-019-1073-3
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29(2):154–159. doi:10.1016/j.clnu.2009.12.004
   PubMed Web of Science ®Google Scholar
• Koehler F, Doehner W, Hoernig S, Witt C, Anker SD, John M. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement. Int J Cardiol. 2007;119(1):83–89. doi:10.1016/j.ijcard.2006.07.088
   PubMed Web of Science ®Google Scholar
• Triest FJJ, Franssen FME, Reynaert N, et al. Disease-specific comorbidity clusters in COPD and accelerated aging. J Clin Med. 2019;8(4):511. doi:10.3390/jcm8040511
   PubMed Web of Science ®Google Scholar
• Arthur ST, Noone JM, Van Doren BA, Roy D, Blanchette CM. One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. Drugs Context. 2014;3:212265. doi:10.7573/dic.212265
   PubMedGoogle Scholar
• Attaway AH, Welch N, Hatipoglu U, Zein JG, Dasarathy S. Muscle loss contributes to higher morbidity and mortality in COPD: an analysis of national trends. Respirology. 2021;26(1):62–71. doi:10.1111/resp.13877
   PubMed Web of Science ®Google Scholar
• Berardi E, Madaro L, Lozanoska-Ochser B, et al. A pound of flesh: what cachexia is and what it is not. Diagnostics. 2021;11(1):116. doi:10.3390/diagnostics11010116
   Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799. doi:10.1016/j.clnu.2008.06.013
   PubMed Web of Science ®Google Scholar
• Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504–1520. doi:10.1183/09031936.00070914
   PubMed Web of Science ®Google Scholar
• Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis. 1989;139(6):1435–1438. doi:10.1164/ajrccm/139.6.1435
   PubMed Web of Science ®Google Scholar
• Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59. doi:10.1093/ajcn/82.1.53
   PubMed Web of Science ®Google Scholar
• Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20(3):539–544. doi:10.1183/09031936.02.00532002
   PubMed Web of Science ®Google Scholar
• Mason SE, Moreta-Martinez R, Labaki WW, et al. Longitudinal association between muscle loss and mortality in ever smokers. Chest. 2022;161(4):960–970. doi:10.1016/j.chest.2021.10.047
   PubMed Web of Science ®Google Scholar
• Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J. 2002;19(4):626–631. doi:10.1183/09031936.02.00279602
   PubMed Web of Science ®Google Scholar
• Cruz Rivera PN, Goldstein RL, Polak M, Lazzari AA, Moy ML, Wan ES. Performance of bioelectrical impedance analysis compared to dual X-ray absorptiometry (DXA) in Veterans with COPD. Sci Rep. 2022;12(1):1946. doi:10.1038/s41598-022-05887-4
   PubMed Web of Science ®Google Scholar
• Sanders KJC, Ash SY, Washko GR, Mottaghy FM, Schols A. Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model. J Appl Physiol. 2018;124(2):512–520. doi:10.1152/japplphysiol.00143.2017
   PubMed Web of Science ®Google Scholar
• McDonald ML, Diaz AA, Ross JC, et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc. 2014;11(3):326–334. doi:10.1513/AnnalsATS.201307-229OC
   PubMedGoogle Scholar
• Sanders KJC, Degens J, Dingemans AC, Schols A. Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer. Int J Chron Obstruct Pulmon Dis. 2019;14:781–789. doi:10.2147/COPD.S194003
   PubMed Web of Science ®Google Scholar
• Mokari-Yamchi A, Jabbari M, Sharifi A, Barati M, Kheirouri S. Low FEV1 is associated with increased risk of cachexia in COPD patients. Int J Chron Obstruct Pulmon Dis. 2019;14:2433–2440. doi:10.2147/COPD.S221466
   PubMed Web of Science ®Google Scholar
• Fermoselle C, Rabinovich R, Ausin P, et al. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J. 2012;40(4):851–862. doi:10.1183/09031936.00137211
   PubMed Web of Science ®Google Scholar
• Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859–867. doi:10.1053/rmed.2000.0829
   PubMed Web of Science ®Google Scholar
• Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006;100(8):1349–1355. doi:10.1016/j.rmed.2005.11.023
   PubMed Web of Science ®Google Scholar
• Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr. 1999;18(5):275–280. doi:10.1016/S0261-5614(98)80024-1
   PubMed Web of Science ®Google Scholar
• Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol. 2013;114(9):1253–1262. doi:10.1152/japplphysiol.00790.2012
   PubMed Web of Science ®Google Scholar
• Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc. 2006;38(9):1543–1552. doi:10.1249/01.mss.0000228331.13123.53
   PubMed Web of Science ®Google Scholar
• Skyba P, Ukropec J, Pobeha P, et al. Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators Inflamm. 2010;2010:173498. doi:10.1155/2010/173498
   PubMed Web of Science ®Google Scholar
• Janssen DJ, Spruit MA, Leue C, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010;7(3):147–157. doi:10.1177/1479972310369285
   PubMedGoogle Scholar
• Yao HM, Xiao RS, Cao PL, Wang XL, Zuo W, Zhang W. Risk factors for depression in patients with chronic obstructive pulmonary disease. World J Psychiatry. 2020;10(4):59–70. doi:10.5498/wjp.v10.i4.59
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. doi:10.1164/rccm.201209-1665OC
   PubMed Web of Science ®Google Scholar
• Sepulveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11(5):1164–1176. doi:10.1002/jcsm.12600
   PubMed Web of Science ®Google Scholar
• Sanders KJC, Kneppers AEM, van de Bool C, Langen RCJ, Schols AM. Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective. J Cachexia Sarcopenia Muscle. 2016;7(1):5–22. doi:10.1002/jcsm.12062
   PubMed Web of Science ®Google Scholar
• Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2013;45(10):2245–2256. doi:10.1016/j.biocel.2013.06.015
   PubMed Web of Science ®Google Scholar
• Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–e62. doi:10.1164/rccm.201402-0373ST
   PubMed Web of Science ®Google Scholar
• Puig-Vilanova E, Rodriguez DA, Lloreta J, et al. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer. Free Radic Biol Med. 2015;79:91–108. doi:10.1016/j.freeradbiomed.2014.11.006
   PubMed Web of Science ®Google Scholar
• Kneppers AEM, Langen RCJ, Gosker HR, et al. Increased myogenic and protein turnover signaling in skeletal muscle of chronic obstructive pulmonary disease patients with sarcopenia. J Am Med Dir Assoc. 2017;18(7):637e1–637 e11. doi:10.1016/j.jamda.2017.04.016
   Web of Science ®Google Scholar
• Rabinovich RA, Bastos R, Ardite E, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J. 2007;29(4):643–650. doi:10.1183/09031936.00086306
   PubMed Web of Science ®Google Scholar
• Remels AH, Gosker HR, Schrauwen P, et al. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J. 2010;24(12):5052–5062. doi:10.1096/fj.09-150714
   PubMed Web of Science ®Google Scholar
• Remels AH, Schrauwen P, Broekhuizen R, et al. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J. 2007;30(2):245–252. doi:10.1183/09031936.00144106
   PubMed Web of Science ®Google Scholar
• Barreiro E, Salazar-Degracia A, Sancho-Munoz A, Gea J. Endoplasmic reticulum stress and unfolded protein response profile in quadriceps of sarcopenic patients with respiratory diseases. J Cell Physiol. 2019;234(7):11315–11329. doi:10.1002/jcp.27789
   PubMed Web of Science ®Google Scholar
• Barreiro E, Sancho-Munoz A, Puig-Vilanova E, et al. Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia. J Appl Physiol. 2019;126(2):403–412. doi:10.1152/japplphysiol.00611.2018
   PubMed Web of Science ®Google Scholar
• Schols AM, Creutzberg EC, Buurman WA, Campfield LA, Saris WH, Wouters EF. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(4):1220–1226. doi:10.1164/ajrccm.160.4.9811033
   PubMed Web of Science ®Google Scholar
• Brusik M, Ukropec J, Joppa P, et al. Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiol Res. 2012;61(5):469–480. doi:10.33549/physiolres.932306
   PubMed Web of Science ®Google Scholar
• Mokari-Yamchi A, Sharifi A, Kheirouri S. Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3157–3163. doi:10.2147/COPD.S172996
   PubMed Web of Science ®Google Scholar
• Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20(3):433–447. doi:10.1016/j.cmet.2014.06.011
   PubMed Web of Science ®Google Scholar
• Sanders KJC, Wierts R, van Marken Lichtenbelt WD, et al. Brown adipose tissue activation is not related to hypermetabolism in emphysematous chronic obstructive pulmonary disease patients. J Cachexia Sarcopenia Muscle. 2022;13:1329–1338. doi:10.1002/jcsm.12881
   PubMed Web of Science ®Google Scholar
• Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31(3):492–501. doi:10.1183/09031936.00074807
   PubMed Web of Science ®Google Scholar
• Wain LV, Shrine N, Artigas MS, et al. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat Genet. 2017;49:416–425. doi:10.1038/ng.3787
   PubMed Web of Science ®Google Scholar
• Prokopenko D, Sakornsakolpat P, Fier HL, et al. Whole-genome sequencing in severe chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2018;59(5):614–622. doi:10.1165/rcmb.2018-0088OC
   PubMed Web of Science ®Google Scholar
• Lutz SM, Cho MH, Hersh CP, et al. A genome-wide association study of spirometric measures of pulmonary function in the COPDGene study. BMC Genet. 2013;16:1–11.
   Google Scholar
• Lutz SM, Cho MH, Young K, et al. A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genet. 2015;16:138. doi:10.1186/s12863-015-0299-4
   PubMed Web of Science ®Google Scholar
• Silverman EK. Genetics of COPD. Annu Rev Physiol. 2020;82:413–431. doi:10.1146/annurev-physiol-021317-121224
   PubMed Web of Science ®Google Scholar
• Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–1455. doi:10.1056/NEJMra1910234
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Forgetta V, Handa T, et al. The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes. Eur Respir J. 2020;56(6):2001441. doi:10.1183/13993003.01441-2020
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):395–399. doi:10.1164/rccm.200304-578OC
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Eleftheriou KI, Payne J, et al. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 2006;83(4):912–917. doi:10.1093/ajcn/83.4.912
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008;87(2):385–390. doi:10.1093/ajcn/87.2.385
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Grimble RF, Howell WM, et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta −511 single nucleotide polymorphism. Am J Clin Nutr. 2005;82(5):1059–1064. doi:10.1093/ajcn/82.5.1059
   PubMed Web of Science ®Google Scholar
• Lakshman Kumar P, Wilson AC, Rocco A, et al. Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2021;12(6):1803–1817. doi:10.1002/jcsm.12782
   PubMed Web of Science ®Google Scholar
• Park HK, Lee SH, Lee SY, Kim SS, Park HW. Relationships between lung function decline and skeletal muscle and fat mass changes: a longitudinal study in healthy individuals. J Cachexia Sarcopenia Muscle. 2021;12(6):2145–2153. doi:10.1002/jcsm.12821
   PubMed Web of Science ®Google Scholar
• Divo MJ, Cabrera C, Casanova C, et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis. 2014;1(2):229–238. doi:10.15326/jcopdf.1.2.2014.0117
   PubMedGoogle Scholar
• Ji Z, de Miguel-diez J, Castro-Riera CR, et al. Differences in the outcome of patients with COPD according to body mass index. J Clin Med. 2020;9(3):710. doi:10.3390/jcm9030710
   PubMed Web of Science ®Google Scholar
• Konokhova Y, Spendiff S, Jagoe RT, et al. Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle. Skelet Muscle. 2016;6:10. doi:10.1186/s13395-016-0083-9
   PubMed Web of Science ®Google Scholar
• Kapchinsky S, Vuda M, Miguez K, et al. Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease. J Physiol. 2018;596(14):2865–2881. doi:10.1113/JP275558
   PubMed Web of Science ®Google Scholar
• Boehm I, Miller J, Wishart TM, et al. Neuromuscular junctions are stable in patients with cancer cachexia. J Clin Invest. 2020;130(3):1461–1465. doi:10.1172/JCI128411
   PubMed Web of Science ®Google Scholar
• Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med. 2015;191(6):620–625. doi:10.1164/rccm.201410-1830PP
   PubMed Web of Science ®Google Scholar
• Cielen N, Maes K, Heulens N, et al. Interaction between physical activity and smoking on lung, muscle, and bone in mice. Am J Respir Cell Mol Biol. 2016;54(5):674–682. doi:10.1165/rcmb.2015-0181OC
   PubMed Web of Science ®Google Scholar
• Toledo-Arruda AC, Sousa Neto IV, Vieira RP, et al. Aerobic exercise training attenuates detrimental effects of cigarette smoke exposure on peripheral muscle through stimulation of the Nrf2 pathway and cytokines: a time-course study in mice. Appl Physiol Nutr Metab. 2020;45(9):978–986. doi:10.1139/apnm-2019-0543
   PubMed Web of Science ®Google Scholar
• Wang L, van Iersel LEJ, Pelgrim CE, et al. Effects of cigarette smoke on adipose and skeletal muscle tissue: in vivo and in vitro studies. Cells. 2022;11(18):2893. doi:10.3390/cells11182893
   PubMed Web of Science ®Google Scholar
• Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary disease: role of hypoxia. Nutrition. 2011;27(2):138–143. doi:10.1016/j.nut.2010.07.009
   PubMed Web of Science ®Google Scholar
• Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199–208. doi:10.2147/COPD.S10611
   PubMed Web of Science ®Google Scholar
• Schols A, Mostert R, Soeters P, Greve LH, Wouters EF. Inventory of nutritional status in patients with COPD. Chest. 1989;96(2):247–249. doi:10.1378/chest.96.2.247
   PubMed Web of Science ®Google Scholar
• Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–1156. doi:10.1164/ajrccm/147.5.1151
   PubMed Web of Science ®Google Scholar
• Debevec T, Ganse B, Mittag U, Eiken O, Mekjavic IB, Rittweger J. Hypoxia aggravates inactivity-related muscle wasting. Front Physiol. 2018;9:494. doi:10.3389/fphys.2018.00494
   PubMed Web of Science ®Google Scholar
• Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax. 2007;62(11):944–949. doi:10.1136/thx.2007.078980
   PubMed Web of Science ®Google Scholar
• Budweiser S, Heinemann F, Meyer K, Wild PJ, Pfeifer M. Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care. 2006;51(2):126–132.
   PubMed Web of Science ®Google Scholar
• Fernandez-Bussy S, Kornafeld A, Labarca G, Abia-Trujillo D, Patel NM, Herth FJF. Endoscopic lung volume reduction in relation to body mass index in patients with severe heterogeneous emphysema. Respiration. 2020;99(6):477–483. doi:10.1159/000507591
   PubMed Web of Science ®Google Scholar
• O’Corragain OA, Townsend R, Lashari B, Sinha T, van der Rijst N, Criner GJ. Weight gain following bronchoscopic lung volume reduction. Am J Respir Crit Care Med. 2022;2022:A2134.
   Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• De Brandt J, Spruit MA, Hansen D, et al. Changes in lower limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: a review of the English-language literature. Chron Respir Dis. 2018;15(2):182–219. doi:10.1177/1479972317709642
   PubMed Web of Science ®Google Scholar
• Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. doi:10.1136/thoraxjnl-2014-206440
   PubMed Web of Science ®Google Scholar
• Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One. 2014;9(10):e110448. doi:10.1371/journal.pone.0110448
   PubMed Web of Science ®Google Scholar
• Lee DW, Jin HJ, Shin KC, Chung JH, Lee HW, Lee KH. Presence of sarcopenia in asthma-COPD overlap syndrome may be a risk factor for decreased bone-mineral density, unlike asthma: Korean National Health and Nutrition Examination Survey (KNHANES) IV and V (2008–2011). Int J Chron Obstruct Pulmon Dis. 2017;12:2355–2362. doi:10.2147/COPD.S138497
   PubMed Web of Science ®Google Scholar
• Lee DW, Choi EY, Wu Q. Sarcopenia as an independent risk factor for decreased BMD in COPD patients: Korean National Health and Nutrition Examination Surveys IV and V (2008–2011). PLoS One. 2016;11(10):e0164303. doi:10.1371/journal.pone.0164303
   PubMed Web of Science ®Google Scholar
• Matkovic Z, Cvetko D, Rahelic D, et al. Nutritional status of patients with chronic obstructive pulmonary disease in relation to their physical performance. COPD. 2017;14(6):626–634. doi:10.1080/15412555.2017.1386643
   PubMedGoogle Scholar
• Andersson M, Slinde F, Gronberg AM, Svantesson U, Janson C, Emtner M. Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study. Respir Res. 2013;14:128. doi:10.1186/1465-9921-14-128
   PubMed Web of Science ®Google Scholar
• Matkovic Z, Tudoric N, Cvetko D, et al. Easy to perform physical performance tests to identify COPD patients with low physical activity in clinical practice. Int J Chron Obstruct Pulmon Dis. 2020;15:921–929. doi:10.2147/COPD.S246571
   PubMed Web of Science ®Google Scholar
• Waschki B, Spruit MA, Watz H, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med. 2012;106(4):522–530. doi:10.1016/j.rmed.2011.10.022
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40(5):1115–1122. doi:10.1183/09031936.00170111
   PubMed Web of Science ®Google Scholar
• Bossenbroek L, de Greef MH, Wempe JB, Krijnen WP, Ten Hacken NH. Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD. 2011;8(4):306–319. doi:10.3109/15412555.2011.578601
   PubMedGoogle Scholar
• Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014;145(3):542–550. doi:10.1378/chest.13-1052
   PubMed Web of Science ®Google Scholar
• Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.00046814
   PubMed Web of Science ®Google Scholar
• Kantorowski A, Wan ES, Homsy D, Kadri R, Richardson CR, Moy ML. Determinants and outcomes of change in physical activity in COPD. ERJ Open Res. 2018;4(3):00054–2018. doi:10.1183/23120541.00054-2018
   PubMedGoogle Scholar
• Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991;54(6):983–987. doi:10.1093/ajcn/54.6.983
   PubMed Web of Science ®Google Scholar
• Green JH, Muers MF. The thermic effect of food in underweight patients with emphysematous chronic obstructive pulmonary disease. Eur Respir J. 1991;4(7):813–819.
   PubMed Web of Science ®Google Scholar
• Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Heijdra YF. Physiologic limitations during daily life activities in COPD patients. Respir Med. 2010;104(8):1152–1159. doi:10.1016/j.rmed.2010.02.011
   PubMed Web of Science ®Google Scholar
• Vaes AW, Wouters EFM, Franssen FME, et al. Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest. 2011;140(4):970–979. doi:10.1378/chest.10-3005
   PubMed Web of Science ®Google Scholar
• Schols AM, Soeters PB, Mostert R, Saris WH, Wouters EF. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;143(6):1248–1252. doi:10.1164/ajrccm/143.6.1248
   PubMed Web of Science ®Google Scholar
• Christensen T, Mikkelsen S, Geisler L, Holst M. Chronic obstructive pulmonary disease outpatients bear risks of both unplanned weight loss and obesity. Clin Nutr ESPEN. 2022;49:246–251. doi:10.1016/j.clnesp.2022.04.010
   PubMed Web of Science ®Google Scholar
• Rom O, Reznick AZ. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med. 2016;98:218–230. doi:10.1016/j.freeradbiomed.2015.12.031
   PubMed Web of Science ®Google Scholar
• Steiner JL, Lang CH. Dysregulation of skeletal muscle protein metabolism by alcohol. Am J Physiol Endocrinol Metab. 2015;308(9):E699–712. doi:10.1152/ajpendo.00006.2015
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang F, Modrak S, Little A, Zhang H. Chronic alcohol consumption enhances skeletal muscle wasting in mice bearing cachectic cancers: the role of tnfalpha/myostatin axis. Alcohol Clin Exp Res. 2020;44(1):66–77. doi:10.1111/acer.14221
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang F, Zhang H, et al. Alcohol intake aggravates adipose browning and muscle atrophy in cancer-associated cachexia. Oncotarget. 2017;8(59):100411–100420. doi:10.18632/oncotarget.22243
   PubMedGoogle Scholar
• Preedy VR, Adachi J, Ueno Y, et al. Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis. Eur J Neurol. 2001;8(6):677–687. doi:10.1046/j.1468-1331.2001.00303.x
   PubMed Web of Science ®Google Scholar
• Dasarathy J, McCullough AJ, Dasarathy S. Sarcopenia in alcoholic liver disease: clinical and molecular advances. Alcohol Clin Exp Res. 2017;41(8):1419–1431. doi:10.1111/acer.13425
   PubMed Web of Science ®Google Scholar
• Prokopidis K, Witard OC. Understanding the role of smoking and chronic excess alcohol consumption on reduced caloric intake and the development of sarcopenia. Nutr Res Rev. 2021;1–10. doi:10.1017/S0954422421000135
   Web of Science ®Google Scholar
• Hansen H, Johnsen NF, Molsted S. Time trends in leisure time physical activity, smoking, alcohol consumption and body mass index in Danish adults with and without COPD. BMC Pulm Med. 2016;16(1):110. doi:10.1186/s12890-016-0265-6
   PubMed Web of Science ®Google Scholar
• Crul T, Testelmans D, Spruit MA, et al. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem. 2010;25(4–5):491–500. doi:10.1159/000303054
   PubMed Web of Science ®Google Scholar
• Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150(1):11–16. doi:10.1164/ajrccm.150.1.8025735
   PubMed Web of Science ®Google Scholar
• Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629–634. doi:10.1164/ajrccm.158.2.9711023
   PubMed Web of Science ®Google Scholar
• Snyder-Mackler N, Burger JR, Gaydosh L, et al. Social determinants of health and survival in humans and other animals. Science. 2020;368(6493). doi:10.1126/science.aax9553
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200(5):556–564. doi:10.1164/rccm.201810-1975TR
   PubMed Web of Science ®Google Scholar
• Divo M, Celli BR. Multimorbidity in patients with chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):405–419. doi:10.1016/j.ccm.2020.06.002
   PubMed Web of Science ®Google Scholar
• Goris AH, Vermeeren MA, Wouters EF, Schols AM, Westerterp KR. Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation. Br J Nutr. 2003;89(5):725–731. doi:10.1079/BJN2003838
   PubMed Web of Science ®Google Scholar
• Baarends EM, Schols AM, Westerterp KR, Wouters EF. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax. 1997;52(9):780–785. doi:10.1136/thx.52.9.780
   PubMed Web of Science ®Google Scholar
• Hugli O, Schutz Y, Fitting JW. The daily energy expenditure in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(1):294–300. doi:10.1164/ajrccm.153.1.8542132
   PubMed Web of Science ®Google Scholar
• Slinde F, Ellegard L, Gronberg AM, Larsson S, Rossander-Hulthen L. Total energy expenditure in underweight patients with severe chronic obstructive pulmonary disease living at home. Clin Nutr. 2003;22(2):159–165. doi:10.1054/clnu.2002.0618
   PubMed Web of Science ®Google Scholar
• Vermeeren MA, Schols AM, Wouters EF. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J. 1997;10(10):2264–2269. doi:10.1183/09031936.97.10102264
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Creutzberg EC, Weling-Scheepers CA, Wouters EF, Schols AM. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease. Br J Nutr. 2005;93(6):965–971. doi:10.1079/BJN20051437
   PubMed Web of Science ®Google Scholar
• Deutz NE, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33(6):929–936. doi:10.1016/j.clnu.2014.04.007
   PubMed Web of Science ®Google Scholar
• Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE. Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2007;85(2):431–439. doi:10.1093/ajcn/85.2.431
   PubMed Web of Science ®Google Scholar
• Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE. Casein protein results in higher prandial and exercise induced whole body protein anabolism than whey protein in chronic obstructive pulmonary disease. Metabolism. 2012;61(9):1289–1300. doi:10.1016/j.metabol.2012.03.001
   PubMed Web of Science ®Google Scholar
• Jonker R, Deutz NE, Erbland ML, Anderson PJ, Engelen MP. Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion. Clin Nutr. 2014;33(2):211–220. doi:10.1016/j.clnu.2013.06.014
   PubMed Web of Science ®Google Scholar
• Jonker R, Deutz NEP, Schols A, et al. Whole body protein anabolism in COPD patients and healthy older adults is not enhanced by adding either carbohydrates or leucine to a serving of protein. Clin Nutr. 2019;38(4):1684–1691. doi:10.1016/j.clnu.2018.08.006
   PubMed Web of Science ®Google Scholar
• Engelen M, Deutz NEP. Is beta-hydroxy beta-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations? Curr Opin Clin Nutr Metab Care. 2018;21(3):207–213. doi:10.1097/MCO.0000000000000459
   PubMed Web of Science ®Google Scholar
• Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD000998. doi:10.1002/14651858.CD000998.pub3
   PubMed Web of Science ®Google Scholar
• Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179(8):630–636. doi:10.1164/rccm.200810-1576PP
   PubMed Web of Science ®Google Scholar
• Ryan ZC, Craig TA, Folmes CD, et al. 1alpha, 25-dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J Biol Chem. 2016;291(3):1514–1528. doi:10.1074/jbc.M115.684399
   PubMed Web of Science ®Google Scholar
• Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int. 2011;22(3):859–871. doi:10.1007/s00198-010-1407-y
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Haghighat N, Hakimrabet M, Tolide-ie H. Nutritional evaluation in chronic obstructive pulmonary disease patients. Pak J Biol Sci. 2012;15(10):501–505. doi:10.3923/pjbs.2012.501.505
   PubMedGoogle Scholar
• Calder PC, Laviano A, Lonnqvist F, Muscaritoli M, Öhlander M, Schols A. Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial. J Cachexia Sarcopenia Muscle. 2018;9(1):28–40. doi:10.1002/jcsm.12228
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Wouters EF, Creutzberg EC, Weling-Scheepers CA, Schols AM. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax. 2005;60(5):376–382. doi:10.1136/thx.2004.030858
   PubMed Web of Science ®Google Scholar
• van de Bool C, Rutten EPA, van Helvoort A, Franssen FME, Wouters EFM, Schols A. A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD. J Cachexia Sarcopenia Muscle. 2017;8(5):748–758. doi:10.1002/jcsm.12219
   PubMed Web of Science ®Google Scholar
• van Beers M, Rutten-van Mölken M, van de Bool C, et al. Clinical outcome and cost-effectiveness of a 1-year nutritional intervention programme in COPD patients with low muscle mass: the randomized controlled NUTRAIN trial. Clin Nutr. 2020;39(2):405–413. doi:10.1016/j.clnu.2019.03.001
   PubMed Web of Science ®Google Scholar
• van Wetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc. 2010;11(3):179–187. doi:10.1016/j.jamda.2009.12.083
   PubMed Web of Science ®Google Scholar
• Lainscak M, Gosker HR, Schols AM. Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention. Curr Opin Clin Nutr Metab Care. 2013;16(3):278–283. doi:10.1097/MCO.0b013e328360285d
   PubMed Web of Science ®Google Scholar
• Vermeeren MA, Wouters EF, Geraerts-Keeris AJ, Schols AM. Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. Clin Nutr. 2004;23(5):1184–1192. doi:10.1016/j.clnu.2004.03.008
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1239–1245. doi:10.1164/ajrccm.162.4.9912016
   PubMed Web of Science ®Google Scholar
• Zinna EM, Yarasheski KE. Exercise treatment to counteract protein wasting of chronic diseases. Curr Opin Clin Nutr Metab Care. 2003;6(1):87–93. doi:10.1097/00075197-200301000-00013
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. doi:10.1164/rccm.201309-1634ST
   PubMed Web of Science ®Google Scholar
• Marillier M, Bernard AC, Verges S, Neder JA. Locomotor muscles in COPD: the rationale for rehabilitative exercise training. Front Physiol. 2019;10:1590. doi:10.3389/fphys.2019.01590
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Stratakos G, Simoes DC, et al. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax. 2007;62(11):950–956. doi:10.1136/thx.2006.069310
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Terzis G, Nanas S, et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest. 2005;128(6):3838–3845. doi:10.1378/chest.128.6.3838
   PubMed Web of Science ®Google Scholar
• De Brandt J, Spruit MA, Derave W, Hansen D, Vanfleteren LE, Burtin C. Changes in structural and metabolic muscle characteristics following exercise-based interventions in patients with COPD: a systematic review. Expert Rev Respir Med. 2016;10(5):521–545. doi:10.1586/17476348.2016.1157472
   PubMed Web of Science ®Google Scholar
• Troosters T, Blondeel A, Janssens W, Demeyer H. The past, present and future of pulmonary rehabilitation. Respirology. 2019;24(9):830–837. doi:10.1111/resp.13517
   PubMed Web of Science ®Google Scholar
• Beauchamp MK, Nonoyama M, Goldstein RS, et al. Interval versus continuous training in individuals with chronic obstructive pulmonary disease--a systematic review. Thorax. 2010;65(2):157–164. doi:10.1136/thx.2009.123000
   PubMed Web of Science ®Google Scholar
• Dolmage TE, Goldstein RS. Effects of one-legged exercise training of patients with COPD. Chest. 2008;133(2):370–376. doi:10.1378/chest.07-1423
   PubMed Web of Science ®Google Scholar
• Bronstad E, Rognmo O, Tjonna AE, et al. High-intensity knee extensor training restores skeletal muscle function in COPD patients. Eur Respir J. 2012;40(5):1130–1136. doi:10.1183/09031936.00193411
   PubMed Web of Science ®Google Scholar
• Nyberg A, Martin M, Saey D, et al. Effects of low-load/high-repetition resistance training on exercise capacity, health status, and limb muscle adaptation in patients with severe COPD: a randomized controlled trial. Chest. 2020;159:1821–1832. doi:10.1016/j.chest.2020.12.005
   PubMed Web of Science ®Google Scholar
• Nyberg A, Saey D, Martin M, Maltais F. Cardiorespiratory and muscle oxygenation responses to low-load/high-repetition resistance exercises in COPD and healthy controls. J Appl Physiol. 2018;124(4):877–887. doi:10.1152/japplphysiol.00447.2017
   PubMed Web of Science ®Google Scholar
• O’Shea SD, Taylor NF, Paratz JD. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest. 2009;136(5):1269–1283. doi:10.1378/chest.09-0029
   PubMed Web of Science ®Google Scholar
• Schoenfeld BJ, Grgic J, Ogborn D, Krieger JW. Strength and hypertrophy adaptations between low- vs. high-load resistance training: a systematic review and meta-analysis. J Strength Cond Res. 2017;31(12):3508–3523. doi:10.1519/JSC.0000000000002200
   PubMed Web of Science ®Google Scholar
• Schoenfeld BJ, Grgic J, Van Every DW, Plotkin DL. Loading recommendations for muscle strength, hypertrophy, and local endurance: a re-examination of the repetition continuum. Sports. 2021;9(2):32. doi:10.3390/sports9020032
   Web of Science ®Google Scholar
• Constantin D, Menon MK, Houchen-Wolloff L, et al. Skeletal muscle molecular responses to resistance training and dietary supplementation in COPD. Thorax. 2013;68(7):625–633. doi:10.1136/thoraxjnl-2012-202764
   PubMed Web of Science ®Google Scholar
• Costes F, Gosker H, Feasson L, et al. Impaired exercise training-induced muscle fiber hypertrophy and Akt/mTOR pathway activation in hypoxemic patients with COPD. J Appl Physiol. 2015;118(8):1040–1049. doi:10.1152/japplphysiol.00557.2014
   PubMed Web of Science ®Google Scholar
• Hill K, Cavalheri V, Mathur S, et al. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;5(5):Cd010821. doi:10.1002/14651858.CD010821.pub2
   PubMed Web of Science ®Google Scholar
• Maddocks M, Nolan CM, Man WD, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial. Lancet Respir Med. 2016;4(1):27–36. doi:10.1016/s2213-2600(15)00503-2
   PubMed Web of Science ®Google Scholar
• Wouters EFM, Augustin IML. Process of pulmonary rehabilitation and program organization. Eur J Phys Rehabil Med. 2011;47(3):475–482.
   PubMed Web of Science ®Google Scholar
• Franssen FME, Vanfleteren LE, Janssen DJA, Wouters EFM, Spruit MA. Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure. Breathe. 2019;15(3):227–233. doi:10.1183/20734735.0186-2019
   Web of Science ®Google Scholar
• Bolton CE, Broekhuizen R, Ionescu AA, et al. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax. 2007;62(2):109–114. doi:10.1136/thx.2006.060368
   PubMed Web of Science ®Google Scholar
• Holland AE, Cox NS, Houchen-Wolloff L, et al. Defining modern pulmonary rehabilitation. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2021;18(5):e12–e29. doi:10.1513/AnnalsATS.202102-146ST
   PubMed Web of Science ®Google Scholar
• Kneppers AEM, Haast RAM, Langen RCJ, et al. Distinct skeletal muscle molecular responses to pulmonary rehabilitation in chronic obstructive pulmonary disease: a cluster analysis. J Cachexia Sarcopenia Muscle. 2019;10(2):311–322. doi:10.1002/jcsm.12370
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Simoes DC, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J. 2010;36(2):301–310. doi:10.1183/09031936.00112909
   PubMed Web of Science ®Google Scholar
• Wan ES, Cho MH, Boutaoui N, et al. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2011;45(2):304–310. doi:10.1165/rcmb.2010-0294OC
   PubMed Web of Science ®Google Scholar
• Miki K, Maekura R, Nagaya N, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. 2012;7(5):e35708. doi:10.1371/journal.pone.0035708
   PubMed Web of Science ®Google Scholar
• Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest. 2005;128(3):1187–1193. doi:10.1378/chest.128.3.1187
   PubMed Web of Science ®Google Scholar
• Weisberg J, Wanger J, Olson J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest. 2002;121(4):1070–1078. doi:10.1378/chest.121.4.1070
   PubMed Web of Science ®Google Scholar
• McKeaveney C, Maxwell P, Noble H, Reid J. A critical review of multimodal interventions for cachexia. Adv Nutr. 2021;12(2):523–532. doi:10.1093/advances/nmaa111
   PubMed Web of Science ®Google Scholar
• Casaburi R, Nakata J, Bistrong L, Torres E, Rambod M, Porszasz J. Effect of megestrol acetate and testosterone on body composition and hormonal responses in COPD cachexia. Chronic Obstr Pulm Dis. 2015;3(1):389–397. doi:10.15326/jcopdf.3.1.2015.0128
   PubMedGoogle Scholar
• Garcia JM, Boccia RV, Graham CD, et al. Anamorelin for patients with cancer cachexia: an integrated analysis of two Phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 2015;16(1):108–116. doi:10.1016/s1470-2045(14)71154-4
   PubMed Web of Science ®Google Scholar
• Currow DC, Abernethy AP. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome. Future Oncol. 2014;10(5):789–802. doi:10.2217/fon.14.14
   PubMed Web of Science ®Google Scholar
• Mantovani G, Macciò A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncog. 1998;9(2):99–106. doi:10.1615/critrevoncog.v9.i2.10
   PubMed Web of Science ®Google Scholar
• Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(8):870–878. doi:10.1164/rccm.200305-617OC
   PubMed Web of Science ®Google Scholar
• Lewis MI, Fournier M, Storer TW, et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol. 2007;103(4):1299–1310. doi:10.1152/japplphysiol.00150.2007
   PubMed Web of Science ®Google Scholar
• Barreiro E, Puig-Vilanova E, Salazar-Degracia A, Pascual-Guardia S, Casadevall C, Gea J. The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia. J Appl Physiol. 2018;125(2):287–303. doi:10.1152/japplphysiol.00798.2017
   PubMed Web of Science ®Google Scholar
• Polkey MI, Praestgaard J, Berwick A, et al. Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease. A randomized trial. Am J Respir Crit Care Med. 2019;199(3):313–320. doi:10.1164/rccm.201802-0286OC
   PubMed Web of Science ®Google Scholar
• Di Girolamo FG, Guadagni M, Fiotti N, Situlin R, Biolo G. Contraction and nutrition interaction promotes anabolism in cachectic muscle. Curr Opin Clin Nutr Metab Care. 2019;22(1):60–67. doi:10.1097/mco.0000000000000527
   PubMed Web of Science ®Google Scholar
• Wilson JMG, Jungner G; World Health Organization. Principles and practice of screening for disease; 2022. Available from: https://apps.who.int/iris/handle/10665/37650. Accessed November 1, 2022.
   Google Scholar
• Spruit MA, Wouters EFM. Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases. Respirology. 2019;24(9):838–843. doi:10.1111/resp.13512
   PubMed Web of Science ®Google Scholar
• Rochester CL, Vogiatzis I, Holland AE, et al. An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373–1386. doi:10.1164/rccm.201510-1966ST
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Rochester CL, Spruit MA, Troosters T, Clini EM. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J. 2016;47(5):1336–1341. doi:10.1183/13993003.02151-2015
   PubMed Web of Science ®Google Scholar
• van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van molken MP, Schols AM. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax. 2010;65(1):7–13. doi:10.1136/thx.2009.118620
   PubMed Web of Science ®Google Scholar
• Pison CM, Cano NJ, Cherion C, et al. Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax. 2011;66(11):953–960. doi:10.1136/thx.2010.154922
   PubMed Web of Science ®Google Scholar
• Baldi S, Aquilani R, Pinna GD, Poggi P, De martini A, Bruschi C. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis. 2010;5:29–39. doi:10.2147/copd.s7739
   PubMedGoogle Scholar
• Liao WH, Chen JW, Chen X, et al. Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care. 2015;60(8):1130–1145. doi:10.4187/respcare.03598
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41(3):687–708. doi:10.1249/MSS.0b013e3181915670
   PubMed Web of Science ®Google Scholar
• Kraemer WJ, Ratamess NA. Fundamentals of resistance training: progression and exercise prescription. Med Sci Sports Exerc. 2004;36(4):674–688. doi:10.1249/01.mss.0000121945.36635.61
   PubMed Web of Science ®Google Scholar
• Chen L, Nelson DR, Zhao Y, Cui Z, Johnston JA. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. BMC Geriatr. 2013;13(1):74. doi:10.1186/1471-2318-13-74
   PubMed Web of Science ®Google Scholar
• Menon MK, Houchen L, Singh SJ, Morgan MD, Bradding P, Steiner MC. Inflammatory and satellite cells in the quadriceps of patients with COPD and response to resistance training. Chest. 2012;142(5):1134–1142. doi:10.1378/chest.11-2144
   PubMed Web of Science ®Google Scholar
• Ramos D, Bertolini GN, Leite MR, et al. Is dynamometry able to infer the risk of muscle mass loss in patients with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1403–1407. doi:10.2147/copd.s69829
   PubMed Web of Science ®Google Scholar
• Gephine S, Frykholm E, Nyberg A, et al. Specific contribution of quadriceps muscle strength, endurance, and power to functional exercise capacity in people with chronic obstructive pulmonary disease: a multicenter study. Phys Ther. 2021;101(6). doi:10.1093/ptj/pzab052
   PubMed Web of Science ®Google Scholar
• Zanini A, Aiello M, Cherubino F, et al. The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:2423–2430. doi:10.2147/COPD.S91176
   PubMed Web of Science ®Google Scholar
• Argilés JM, Campos N, Lopez-Pedrosa JM, Rueda R, Rodriguez-Mañas L. Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J Am Med Dir Assoc. 2016;17(9):789–796. doi:10.1016/j.jamda.2016.04.019
   PubMed Web of Science ®Google Scholar
• Orsso CE, Montes-Ibarra M, Findlay M, et al. Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research. J Cachexia Sarcopenia Muscle. 2022;13(3):1442–1459. doi:10.1002/jcsm.12954
   PubMed Web of Science ®Google Scholar